Quest Systems, Inc. v. Zepp

552 N.E.2d 593, 28 Mass. App. Ct. 489, 1990 Mass. App. LEXIS 221
CourtMassachusetts Appeals Court
DecidedApril 13, 1990
DocketNo. 89-P-47
StatusPublished
Cited by5 cases

This text of 552 N.E.2d 593 (Quest Systems, Inc. v. Zepp) is published on Counsel Stack Legal Research, covering Massachusetts Appeals Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quest Systems, Inc. v. Zepp, 552 N.E.2d 593, 28 Mass. App. Ct. 489, 1990 Mass. App. LEXIS 221 (Mass. Ct. App. 1990).

Opinion

Kaplan, J.

The plaintiff, Quest Systems, Inc. (Quest), moved during the preliminaries of the action, before trial, to dismiss it without prejudice. A judge of the Superior Court dismissed the action with prejudice. He denied any award of counsel fees to the defendant Dr. Zepp. Quest appeals, protesting the “with prejudice” feature of the dismissal; Zepp cross-appeals, protesting the refusal to allow counsel fees. We hold that there was insufficient basis for imposing the “with prejudice” condition, and, on remand, Zepp will be entitled, in connection with the dismissal without prejudice, to [490]*490the consideration on ordinary principles of his application for counsel fees.

Pleadings. We sketch the story as disclosed, first, in the pleadings. According to the complaint (filed on April 3, 1987), Zepp and Dr. Irena Bronstein, who had worked together on certain biotechnological studies and research, founded in April, 1986, The Charles Institute, Inc. (Charles Institute), to develop commercial uses for this research. Quest has succeeded to Charles Institute by merger.

Even before the founding of Charles Institute, Zepp and Bronstein had consulted with Professor A. Paul Schaap of Wayne State University (Wayne State) about Schaap’s research; Zepp and Bronstein had, indeed, entered with Schaap into mutual nondisclosure agreements.

In June, 1986, Zepp resigned from Charles Institute and in that connection he executed, on June 13, 1986, an assignment to Charles Institute of his rights to inventions conceived' or developed while he was with Charles Institute or was working earlier with Bronstein. Zepp agreed in the same document not to disclose any of the inventions to third parties, nor to compete with Charles Institute.

Meanwhile, in June, 1986, Charles Institute, through Bronstein, and Wayne State, by Schaap, were negotiating a licensing agreement under which, in consideration of payments to Wayne State and Schaap, Wayne State would grant to Charles Institute the exclusive commercial use of Schaap’s research achievements in the field of chemical compounds called dioxetanes. The negotiations failed.

After Zepp’s departure from Charles Institute, Bronstein filed an application for patent with respect to inventions by Zepp and Bronstein which were — it is averred — part of the subject matter of Zepp’s assignment to Charles Institute. Zepp, however, in alleged violation of that assignment, refused to join in the patent application or to sign as a coinventor certain documents which were required by the Patent Office. Wayne State, learning of the patent application — a confidential document — sought to secure access to it. For this, Wayne State needed permission from one of the [491]*491named coinventors. Accordingly it solicited and secured from Zepp on November 17, 1986, an assignment of his rights in the inventions Bronstein had listed in the patent application and any patent that might be issued. This second assignment is alleged to contradict and to be in breach of Zepp’s assignment of June 13, 1986, to Charles Institute (Wayne State and Schaap had prior knowledge of that assignment). Although the Patent Office rejected Wayne State’s initial petition to inspect the patent application because the petition was not executed by Zepp, it was understood that the office would allow access to Zepp upon proper request.

The plaintiff feared that, to its irreparable harm, Zepp would, under color of his assignment to Wayne State, and in breach of his assignment to Charles Institute, disclose to Wayne State the substance of the patent application.

The plaintiff Quest in count I charged Zepp with breach of contract (the June 13, 1986, assignment) and violation of other duties owed to it; and, in count II, with unfair and deceptive practices in violation of G. L. c. 93A, §§ 2 and 11. In addition to monetary damages, Quest in its count III and “claims for relief’ sought specific performance by Zepp of his assignment of June 13, 1986, and relief against his disclosing confidential information belonging to Quest; against his seeking to obtain access to patent applications for inventions of Bronstein and Zepp; against his transferring his rights or interest in any inventions created or developed in collaboration with Charles Institute or Bronstein; and against his disclosing information previously assigned to Charles Institute.

By his answer, Zepp, after sundry denials, set up as defenses (inter alia) that the assignment of June 13, 1986, was obtained by fraud and misrepresentation, or arose from mutual mistake, or (on a possible reading) lacked consideration; also that any claim being asserted by Quest was preempted by Federal law, and that G. L. c. 93A was inapplicable.

Application for preliminary injunction. The plaintiff Quest secured a temporary restraining order but its applica[492]*492tion for a preliminary injunction failed after hearing on April 22, 1987.1

Bronstein’s affidavit in support of the application stated that she and Zepp investigated a series of chemical compounds known as dioxetanes or 1, 2 dioxetanes which emit light under certain conditions as protein labels or enzymatic substrates; and they invented a means of triggering light from 1, 2 dioxetanes by means of enzymes. Zepp’s assignment of June 13, 1986, extended to the invention, especially so, since in a “Schedule A” appended to the instrument of assignment, listing the subject matter assigned by Zepp to Charles Institute, the following items appeared: “Dioxetanes as labels for proteins and haptens” and “Dioxetanes as enzymatic substrates.” And the patent application naming Zepp as a coinventor with Bronstein was entitled “Method of Detecting a Substance Using Enzymatically-Induced Decomposition of Dioxetanes.” Zepp, however, wrongfully refused to sponsor the patent application, and wrongfully executed the November 17, 1986, assignment purporting to assign his rights in favor of Wayne State, including those entering into the patent application, which he had previously assigned to Charles Institute. Bronstein asserted that Zepp’s actions, which questioned ownership by Quest, had created problems for Quest with potential investors.

Dr. Zepp, in his affidavit opposing the application, said he executed the June 13, 1986, assignment on the understanding that it was limited to an undertaking by him not to compete. With respect to the technological area which he understood to be the subject of dispute in this lawsuit — “enzyme-induced dioxetane decomposition” — neither he nor Bronstein had done any research. For this reason he refused to join in the patent application. He thought any proprietary rights belonged to. Schaap and Wayne State; therefore he executed the assignment of November 17, 1986. He understood that there was now a dispute regarding rights between Charles [493]*493Institute (Quest) and Wayne State over ownership of Schaap’s research.2

Schaap’s affidavit opposing the preliminary injunction stressed his career-long research in dioxetanes. In discussions with Zepp and Bronstein prior to the founding of Charles Institute, he had described his recent success in stabilizing dioxetanes and triggering chemiluminescent decomposition. Zepp at that time suggested that Schaap consider enzyme-induced dioxetane decomposition. Bronstein offered no opinion and made no comment on Zepp’s suggestion.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lavina v. Satin
33 Mass. L. Rptr. 30 (Massachusetts Superior Court, 2015)
Genuine Parts Co. v. Autopart International, Inc.
27 Mass. L. Rptr. 144 (Massachusetts Superior Court, 2010)
Medeiros v. Middlesex Insurance
716 N.E.2d 1076 (Massachusetts Appeals Court, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
552 N.E.2d 593, 28 Mass. App. Ct. 489, 1990 Mass. App. LEXIS 221, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quest-systems-inc-v-zepp-massappct-1990.